Results 301 to 310 of about 121,038 (379)

Safety and pharmacodynamics of the ferroportin inhibitor vamifeport in patients with non-transfusion-dependent β-thalassemia: results from a randomized phase 2a study. [PDF]

open access: yesOrphanet J Rare Dis
Kattamis A   +8 more
europepmc   +1 more source

Codanin-1, defective in congenital dyserythropoietic anemia I (CDA-I), regulates erythroid differentiation. [PDF]

open access: yesAnn Hematol
Bosques L   +11 more
europepmc   +1 more source

Mitochondrial iron transport via MFRN1 is required for erythroid cell cycle progression. [PDF]

open access: yesBlood Adv
Perfetto M   +9 more
europepmc   +1 more source

Translation of the Morphological Hallmarks of Dyserythropoiesis to Objective Morphometric Parameters by Imaging Flow Cytometry. [PDF]

open access: yesInt J Lab Hematol
Despoina Violidaki DV   +4 more
europepmc   +1 more source

DDX41 resolves G-quadruplexes to maintain erythroid genome integrity and prevent cGAS-mediated cell death. [PDF]

open access: yesNat Commun
Bi H   +17 more
europepmc   +1 more source

Erythroid activity modulates iron regulation in pathological erythropoiesis: A cross-sectional case-control study. [PDF]

open access: yesIndian J Med Res
Santhakumar S   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy